Concepedia

Publication | Closed Access

Non‐invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low‐level viremia

52

Citations

22

References

2017

Year

Abstract

The combined use of two non-invasive serum biomarkers (APRI and FIB-4) could stratify HCC risk for chronic HBV-infected patients with LLV.

References

YearCitations

Page 1